RELX PLC provides information-based analytics and decision tools for professional and business customers across various sectors. Its revenue comes from four main segments: Risk (approximately 30%), Scientific, Technical & Medical (approximately 30%), Legal (approximately 30%), and Exhibitions (approximately 10%). The Risk segment focuses on analytics for evaluating and predicting risk, while the Scientific, Technical & Medical segment supports advancements in science and healthcare. The Legal segment aids in decision-making with legal and regulatory information, and the Exhibitions segment facilitates market learning and transactions through events. Factors supporting endurance include a diversified portfolio and ongoing demand for analytics, while potential limitations may arise from regulatory changes and competition in the data analytics space.
—
RELX PLC provides information-based analytics and decision tools for professional and business customers across various sectors. Its revenue comes from four main segments: Risk (approximately 30%), Scientific, Technical & Medical (approximately 30%), Legal (approximately 30%), and Exhibitions (approximately 10%). The Risk segment focuses on analytics for evaluating and predicting risk, while the Scientific, Technical & Medical segment supports advancements in science and healthcare. The Legal segment aids in decision-making with legal and regulatory information, and the Exhibitions segment facilitates market learning and transactions through events. Factors supporting endurance include a diversified portfolio and ongoing demand for analytics, while potential limitations may arise from regulatory changes and competition in the data analytics space.
—
Daily adjusted close
RELX PLC provides information-based analytics and decision tools for professional and business customers across various sectors. Its revenue comes from four main segments: Risk (approximately 30%), Scientific, Technical & Medical (approximately 30%), Legal (approximately 30%), and Exhibitions (approximately 10%). The Risk segment focuses on analytics for evaluating and predicting risk, while the Scientific, Technical & Medical segment supports advancements in science and healthcare. The Legal segment aids in decision-making with legal and regulatory information, and the Exhibitions segment facilitates market learning and transactions through events. Factors supporting endurance include a diversified portfolio and ongoing demand for analytics, while potential limitations may arise from regulatory changes and competition in the data analytics space.